The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the ALS study gave um patients you know a pretty high dose of a combination drug of nicotinamide riboside so NR and tertill bean for four months and then it followed basically symptoms of ALS on a functional scale so unfortunately for anybody who has known a patient with with ALS
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the ALS study gave um patients you know a pretty high dose of a combination drug of nicotinamide riboside so NR and terban for four months and then it followed basically symptoms of ALS on a functional scale so unfortunately for anybody who has known a patient with ALS
I believe there is a phase 2 trial ongoing and My Hope um is that the phase 2 trial is significantly larger has um robust inputs and therefore Can Shed light on this question